![Neill Moray MacKenzie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neill Moray MacKenzie
Algemeen Directeur bij Trimunocor Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Kees Lucas | M | - |
Biotecnol Ltd.
![]() Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom.
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | - |
Pedro de Noronha Pissarra | M | - |
Biotecnol Ltd.
![]() Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Russell Smith | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | 10 jaar |
John Bell | M | 71 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Helena Tayton-Martin | M | 57 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | 9 jaar |
Jerry Christopher Benjamin | M | 83 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Frank Armstrong | M | 67 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | 7 jaar |
Iain Charles Wilcock | M | 63 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
James M. T. Cochrane | M | 80 |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Peter Doyle | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Nicholas Cross | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | 8 jaar |
Nick Cross | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Ian Kimber | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
David McGibney | M | - |
Avidex Ltd.
![]() Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigd Koninkrijk | 14 | 100.00% |
Portugal | 1 | 7.14% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Neill Moray MacKenzie
- Persoonlijk netwerk